Atlas Trials

A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies

Clinical trial NCT00162123 · COMPLETED

Trial details

NCT number
NCT00162123
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2006-05-01
Primary completion
2012-09-01
Enrollment
248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.